Cyclacel Pharmaceuticals, INC. (BGMSP) — SC 13G Filings
All SC 13G filings from Cyclacel Pharmaceuticals, INC.. Browse 3 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (3)
- SC 13G Filing — Nov 14, 2024
-
Altium Capital Takes 9.99% Stake in Cyclacel Pharma
— Jan 10, 2024
Altium Capital Management, LP, a New York-based investment firm, reported acquiring a significant stake in Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a phar -
Lind Global Fund II Takes 9.99% Stake in Cyclacel Pharma
— Jan 4, 2024
Lind Global Fund II LP, a New York-based investment firm, reported acquiring 1,000,000 shares of Cyclacel Pharmaceuticals, Inc. common stock, representing 9.99%
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX